Toggle Main Menu Toggle Search

Open Access padlockePrints

Crystallographic fragment screening of CDK2-cyclin A: FragLites map sites of protein-protein interaction

Lookup NU author(s): Dr Ian HopeORCiD, Dr Mathew MartinORCiD, Dr Ziwei Jiang, Professor Mike WaringORCiD, Professor Martin NobleORCiD, Professor Jane EndicottORCiD, Dr Natalie TatumORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Author(s). Sites of protein-protein interaction (PPI) are potentially more selective binding sites for therapeutics than protein substrate-binding sites. PPIs include distinct regions frequently called “hotspots,” sites of key amino acid interactions. Prospective identification of these hotspots through X-ray crystallographic screening could assist in the identification of separation of function mutants for experimental validation, enhance confidence in AI-generated multiprotein complex predictions, and accelerate development of selective chemical probes. To explore these applications, we utilize the FragLite library to examine the binding surfaces of CDK2-cyclin A. The many protein- and peptide-CDK2-cyclin A complexes that have been structurally characterized make this complex an appropriate test case. We show that FragLites comprehensively map both known sites of protein-protein interaction on CDK2-cyclin A and identify a possible uncharacterized site, providing a structural method toward directing mechanistic studies and starting points for chemical probe design.


Publication metadata

Author(s): Hope I, Martin MP, Jiang Z, Waring MJ, Noble MEM, Endicott JA, Tatum NJ

Publication type: Article

Publication status: Published

Journal: Structure

Year: 2025

Pages: Epub ahead of print

Online publication date: 14/08/2025

Acceptance date: 20/07/2025

Date deposited: 06/10/2025

ISSN (print): 0969-2126

ISSN (electronic): 1878-4186

Publisher: Cell Press

URL: https://doi.org/10.1016/j.str.2025.07.016

DOI: 10.1016/j.str.2025.07.016

Data Access Statement: All crystallographic results have been deposited at the Protein DataBank (PDB) https://www.rcsb.org/ and are publicly available. Accession numbers are listed in the key resources table. PDB accession codes for structures used within, but not derived from, this study, CDK2 (PDB 1HCK), CDK2-cyclin A (PDB 6GUC), CDK2-cyclin A-p27 (PDB 1JSU), CDK2-KAP (PDB 1FPZ), CDK2-CKS1 (PDB 1BUH), and CDK2-cyclin A-CDC25A (PDB 8ROZ). This paper does not report original code. Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

PubMed id: 40816275


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Astex Pharmaceuticals
C2115/A21421Cancer Research UK CRUK (closed comp)
Medical Research Council (MR/V029142/1)
MR/N009738/1Medical Research Council (MRC)
Medical Research Council Discovery Medicine North Doctoral Training Partnership studentship

Share